Aptiganel Hydrochloride in Acute Ischemic Stroke
JAMA 286:2673-2682,2718, Albers,G.W.,et al, 2001
Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
JAMA 279:1298-1303, 13041998., Fisher,M.&Bogousslavsky,J., 1998
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Neuronal Regenration After Stroke
NEJM 348:2355-2356, Nadareishvili,Z. &Hallenbeck,J., 2003
Neurology:Then, Now, and in the Future
Arch Neurol 59:1369-1373, McKhann,G.M., 2002
Inclusion Body Myositis and Myopathies
Ann Neurol 38:705-713, Griggs,R.C.,et al, 1995
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
The Results of Clinical Trials in Stroke Rehabilitation Research
Arch Neurol 50:37-44, ottenbacher,K.J.&Jannell,S., 1993
The Use of Fetal Tissue in Research on Parkinson's Disease
NEJM 327:1591-1592, Kassirer,J.P.&Angell,M., 1992
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Research Involv Subj with Dementia & Other Cognitive Impairments:NIH, & Ethical Considerations
Neurol 45:1777-1778, Wichman,A.&Sandler,A.L., 1995
Vascular Dementia:Diagnostic Criteria for Research Studies, Report of the NINDS-AIREN Intern'l Workshop
Neurol 43:250-260, Romas,G.C.,et al, 1993
Use of Twin Cohorts for Research in Alzheimer's Disease
Neurol 43:261-267, Breitner,J.C.S.,et al, 1993